Hypertension in Childhood: Diagnosis & Management.
-
Upload
julian-fleming -
Category
Documents
-
view
243 -
download
3
Transcript of Hypertension in Childhood: Diagnosis & Management.
Hypertension in Childhood: Hypertension in Childhood: Diagnosis & ManagementDiagnosis & Management
CONTINUITY CLINIC
Measuring BP inMeasuring BP in ChildrenChildren
Children >3 years oldChildren >3 years old
Preferred method: Auscultation with appropriate size cuffPreferred method: Auscultation with appropriate size cuff
BP tables include 50BP tables include 50thth, 90, 90thth, 95, 95thth, and 99, and 99thth percentiles by percentiles by gender, age, and height gender, age, and height (compiled by NHBPEP Task Forces)
Confirm an elevated BP on at least 2 additional visitsConfirm an elevated BP on at least 2 additional visits
Consider ABPM (portable 24hr BP device) in evaluating Consider ABPM (portable 24hr BP device) in evaluating “white-coat” HTN, episodic HTN, CRD, DM, autonomic “white-coat” HTN, episodic HTN, CRD, DM, autonomic HTN, etc. HTN, etc.
CONTINUITY CLINIC
Hx of prematurity, very low BW, neonatal complication, NICUHx of prematurity, very low BW, neonatal complication, NICU
Congenital heart diseaseCongenital heart disease
Recurrent URIs, hematuria, or proteinuriaRecurrent URIs, hematuria, or proteinuria
Known renal disease or urologic malformationsKnown renal disease or urologic malformations
FHx of congenital renal diseaseFHx of congenital renal disease
Solid-organ transplantSolid-organ transplant
Malignancy or bone marrow transplantMalignancy or bone marrow transplant
Treatment with drugs know to raise BPTreatment with drugs know to raise BP
Other systemic illnesses associated with HTN Other systemic illnesses associated with HTN (neurofibramatosis, tuberous sclerosis, etc.)(neurofibramatosis, tuberous sclerosis, etc.)
Evidence of elevated intracranial pressureEvidence of elevated intracranial pressure
Measuring BP in Children < 3 yearsMeasuring BP in Children < 3 years
CONTINUITY CLINIC
The Right CuffThe Right Cuff
CONTINUITY CLINIC
CLASSIFICATIONCLASSIFICATIONNORMALNORMAL: : < 90th percentile
PREHYPERTENSION PREHYPERTENSION
Average SBP or DBP that are > 90th to < 95th
percentile <OR> if BP >120/80
HYPERTENSIONHYPERTENSION
Average SBP and/or DBP that is > 95th for age,
gender, and height on 3 separate occasions
Stage I HTNStage I HTN: 95th-99th percentile + 5mm Hg
Stage II HTNStage II HTN: > 99th percentile + 5mm Hg
CONTINUITY CLINIC
PRE-ADOLESCENCE PRE-ADOLESCENCE ADOLESCENCEADOLESCENCE
Primary hypertension 15%–30% Primary hypertension 15%–30% 85%–95%85%–95%
Secondary hypertension Secondary hypertension 70%–85%70%–85% 5%–15% 5%–15% Renal parenchymal disease 60%–70% Renal parenchymal disease 60%–70% Coarctation of the aorta 10%–20% Coarctation of the aorta 10%–20% Renovascular 5%–10% Renovascular 5%–10% Reflux nephropathy 5%–10% Reflux nephropathy 5%–10% Endocrine disorder 3%–5% Endocrine disorder 3%–5% Tumors 1%–5% Tumors 1%–5% Other causes 1%–5% Other causes 1%–5%
Causes of HTNCauses of HTNin Childrenin Children
CONTINUITY CLINIC
HH
II
SS
TT
OO
RR
YYOSA
CONTINUITY CLINIC
PP
HH
YY
SS
II
CC
AA
LL
CONTINUITY CLINIC
LABORATORYLABORATORY
EVALUATIONEVALUATIONSCREENING TESTSSCREENING TESTS
UA and cultureUA and culture
Electrolytes, CaElectrolytes, Ca2+2+, Phos, Phos
BUN/Cr, Uric Acid BUN/Cr, Uric Acid
LipidsLipids
CBC with differentialCBC with differential
CONTINUITY CLINIC
LABS cont’d . . .LABS cont’d . . .
SPECIFIC TESTSSPECIFIC TESTS
Fasting insulin & glucoseFasting insulin & glucose
24-hr urine protein and Cr24-hr urine protein and Cr
Urine and serum catecholaminesUrine and serum catecholamines
Hormone levels (thyroid, adrenal)Hormone levels (thyroid, adrenal)
ECHOECHO
RUSRUS
CONTINUITY CLINIC
Labs cont’d . . .Labs cont’d . . .
SPECIALIZED TESTSSPECIALIZED TESTS
Plasma Renin activity and 24-hr urine NaPlasma Renin activity and 24-hr urine NaRUS with Doppler of renal arteriesRUS with Doppler of renal arteriesCaptopril ChallengeCaptopril ChallengeRenal angiography with renal vein reninsRenal angiography with renal vein reninsMRAMRACaptopril renal scanCaptopril renal scanAmbulatory blood pressure monitoringAmbulatory blood pressure monitoringRenal biopsyRenal biopsy
CONTINUITY CLINIC
MANAGEMENTMANAGEMENT EducateEducate
Incorporate patient AND familyIncorporate patient AND family
Nonpharmacologic measures – TNonpharmacologic measures – Therapeuticherapeutic L Lifestyleifestyle CChangeshanges
Antihypertensive MedsAntihypertensive Meds
Monitor for side effects and treatment responseMonitor for side effects and treatment response
CONTINUITY CLINIC
OVERVIEWOVERVIEW
NORMALNORMAL encourage healthy encourage healthy diet/sleep/exercisediet/sleep/exercise
PRE-HTNPRE-HTN Re-check in 6monthsRe-check in 6monthsTLCTLC
STAGE ISTAGE I Re-check 1-2wks - sooner if sxRe-check 1-2wks - sooner if sxTLCTLC. Initiate pharm tx if indicated. Initiate pharm tx if indicated
STAGE IISTAGE II Evaluate within 1wk, immediately Evaluate within 1wk, immediately if patient with sx if patient with sx TLC + pharmacological tx.TLC + pharmacological tx.
CONTINUITY CLINIC
TTherapeuticherapeutic L Lifestyleifestyle C Changeshanges Diet + Exercise = . . . Diet + Exercise = . . .
Weight loss in obese children results in reduction of both Weight loss in obese children results in reduction of both systolic and diastolic BPsystolic and diastolic BP
Sustained aerobic exercise has a blood-pressure lowering Sustained aerobic exercise has a blood-pressure lowering effect in both normotensive and hypertensive persons effect in both normotensive and hypertensive persons
Whether excessive Na causes hypertension is still under Whether excessive Na causes hypertension is still under debate; nonetheless, hypertensive persons benefit from debate; nonetheless, hypertensive persons benefit from reduction in their Na intake.reduction in their Na intake.
Let’s hear it for DASH (Dietary Approaches to Let’s hear it for DASH (Dietary Approaches to Stop Hypertension)!!Stop Hypertension)!!
CONTINUITY CLINIC
To Give or Not To Give ...MEDS…To Give or Not To Give ...MEDS… When to initiate pharmacological therapyWhen to initiate pharmacological therapy
Symptomatic HTNSymptomatic HTN
Stage II HTNStage II HTN
Stage I HTN refractory to nonpharmacologic therapy.Stage I HTN refractory to nonpharmacologic therapy.
Target-organ damage (LVH, retinopathy, micoralbuminuria)Target-organ damage (LVH, retinopathy, micoralbuminuria)
Stage I hypertension in patients with diabetes mellitusStage I hypertension in patients with diabetes mellitus
CONSIDER if child has additional cardiovascular risks –dyslipidemia, CONSIDER if child has additional cardiovascular risks –dyslipidemia, smoking, obesity, family hx, etc.smoking, obesity, family hx, etc.
CONTINUITY CLINIC
Choosing an Choosing an AntihypertensiveAntihypertensive
““Pediatric clinical trials of antihypertensive drugs have Pediatric clinical trials of antihypertensive drugs have focused only on their ability to lower BP and have not focused only on their ability to lower BP and have not compared the effects of these drugs on clinical endpoints.” compared the effects of these drugs on clinical endpoints.” (NHBPEP Task Force)(NHBPEP Task Force)
Physician preferencePhysician preference
Some diuretics and B-Blockers - long hx of safety/efficacy Some diuretics and B-Blockers - long hx of safety/efficacy
Newer classes: ACEI, CCB, ARBs studied short term – Newer classes: ACEI, CCB, ARBs studied short term – safe and well toleratedsafe and well tolerated
Antihypertensives specific to underlying condition or Antihypertensives specific to underlying condition or concurrent medical conditions (ACEI in DM, CCB or BB in concurrent medical conditions (ACEI in DM, CCB or BB in child with migraines)child with migraines)
CONTINUITY CLINIC
Principles of PharmacotherapyPrinciples of Pharmacotherapy
#1#1 Nonpharmacologic measures should be Nonpharmacologic measures should be incorporated into every hypertensive child’s incorporated into every hypertensive child’s treatment plantreatment plan
#2 #2 Drug therapy should be designed to Drug therapy should be designed to MAXIMIZEMAXIMIZE compliance and compliance and minimizeminimize adverse adverse
effectseffects
#3#3 Stepped Care ApproachStepped Care Approach
#4#4 Step Down TherapyStep Down Therapy